CEO Helen Sabzevari sold 119,250 shares of PGEN at $4.36 on 2026-05-28; post-sale holdings remain substantial at 3,768,872 shares despite company's $-7.9M net loss.
Helen Sabzevari, President and CEO, divested 119,250 shares at $4.36, generating $519,930.00 in proceeds while retaining 3,768,872 shares (3.77M shares) representing meaningful ongoing exposure to PGEN. The company posted a net loss of $-7.9M in its most recent full fiscal year, though revenue surged 146.7% year-over-year to $23.3M, indicating aggressive growth amid operational losses. The stock has since declined 24.5% from its 52-week high of $5.46, trading at $4.12 currently. A 3.1% reduction in holdings by the CEO during unprofitability combined with recent weakness warrants scrutiny into whether this reflects broader confidence constraints or capital management amid the loss-generating stage of growth.